A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/11/2007	US20070237827 Nanoparticles for drug delivery
10/11/2007	US20070237826 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides
10/11/2007	US20070237825 Reusable, nonbioadhesive, microporous hydrogel for hydrating and dehydrating dermatological surfaces prepared from hydroxyalkyl (meth)acrylate, a crosslinking agent, water, aliphatic alcohol (isopropanol), and a fibrous filler
10/11/2007	US20070237824 Sustained-Release Preparations Of Quinolone Antibiotics
10/11/2007	US20070237823 Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
10/11/2007	US20070237822 Testosterone gel and method of use
10/11/2007	US20070237821 Nanogel-based contrast agents for optical molecular imaging
10/11/2007	US20070237820 Pharmaceutical formulations containing a non-steroidal antinflammatory drug and an antiulcerative drug
10/11/2007	US20070237819 Use of sustained release oral solid dosage form; side effect reduction of liver disoders
10/11/2007	US20070237818 Controlled-release formulation of HCV protease inhibitor and methods using the same
10/11/2007	US20070237816 Acetaminophen formulation for joint pain relief
10/11/2007	US20070237815 Dosage forms and methods comprising amlodipine and chlorthalidone
10/11/2007	US20070237814 Novel encochleation methods, cochleates and methods of use
10/11/2007	US20070237813 Cancer-suppressing agents
10/11/2007	US20070237808 Therapeutic belt
10/11/2007	US20070237807 Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
10/11/2007	US20070237806 Multi-functional dental composition
10/11/2007	US20070237805 Calcium phosphate complex in acid containing chewing gum
10/11/2007	US20070237804 Impact of calcium phosphate complex on dental caries
10/11/2007	US20070237799 Osteogenic Composite Matrix, Method for the Production Thereof and Implant and Scaffold for Tissue Engineering Provided with a Coating Formed by Said Osteogenic Composite matrix
10/11/2007	US20070237797 Neural Conduit Agent Dissemination
10/11/2007	US20070237796 Stable High Pl Hydrogel Compositions
10/11/2007	US20070237795 Cryopreservation of Haptenized Tumor Cells
10/11/2007	US20070237783 HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
10/11/2007	US20070237749 Multi-membrane immunoisolation system for cellular transplant
10/11/2007	US20070237741 Medical treatment applications of swellable and deformable microspheres
10/11/2007	US20070237729 Impact of calcium phosphate complex on dental caries
10/11/2007	US20070237725 Calcium phosphate complex and salts in oral delivery systems
10/11/2007	US20070237724 Foamable suspension gel
10/11/2007	US20070237723 Treatment of cough with interferon
10/11/2007	US20070237722 Neural conduit agent dissemination
10/11/2007	US20070235889 Production of multivesicular liposomes
10/11/2007	US20070235365 Rapid Acting Drug Delivery Compositions
10/11/2007	DE102006015271A1 Biguanidhaltige Liposomen Biguanide-liposomes
10/11/2007	CA2650498A1 Orally disintegrating tablets
10/11/2007	CA2648640A1 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
10/11/2007	CA2648280A1 Controlled release delivery device comprising an organosol coat
10/11/2007	CA2648278A1 Drug delivery composition
10/11/2007	CA2647982A1 Solid pharmaceutical preparation containing tramadol
10/11/2007	CA2647770A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment
10/11/2007	CA2647765A1 Coated formulations
10/11/2007	CA2647702A1 A tablet of paracetamol containing an encapsulated flavorant
10/11/2007	CA2647549A1 Bulking of soft tissue
10/11/2007	CA2647497A1 Oral dosage forms including an antiplatelet agent and an acid inhibitor
10/11/2007	CA2647060A1 Synthetic archaeal glycolipid adjuvants
10/11/2007	CA2646175A1 Process for the preparation of water-in-oil and oil-in-water nanoemulsions
10/11/2007	CA2646161A1 Cosmetic and therapeutic stick products comprising microparticles
10/11/2007	CA2646136A1 Film-coated solid dosage forms
10/11/2007	CA2646053A1 Polymeric materials as stomach filler and their preparation
10/11/2007	CA2644699A1 Oral pharmaceutical coated composition for pulsatile release
10/11/2007	CA2639925A1 Technology for preparation of macromolecular microspheres
10/11/2007	CA2616543A1 Particulate compositions comprising alginate and/or alginic acid
10/10/2007	EP1842586A1 Method for preparing composite fine particles
10/10/2007	EP1842585A1 Method for producing fine particle surface-modified with water-soluble substance
10/10/2007	EP1842584A1 Method and device for obtaining micro and nanometric size particles
10/10/2007	EP1842559A1 Particle adjuvant for hifu therapy and the use thereof
10/10/2007	EP1842558A1 Composition for inhibiting expression of target gene
10/10/2007	EP1842557A1 Drug carrier and drug carrier kit for inhibiting fibrosis
10/10/2007	EP1842554A1 Coated magnetic particle containing preparation, process for producing the same and diagnostic therapeutic system
10/10/2007	EP1842551A1 E-selectin for treating or preventing stroke
10/10/2007	EP1842544A2 Alginate compositions
10/10/2007	EP1842534A1 Metoprolol succinate extended release tablets and methods for their preparation
10/10/2007	EP1842533A2 Dosage form that is secured against misuse
10/10/2007	EP1842532A2 Oral sparingly water-soluble antifungal formulations and methods of making the same
10/10/2007	EP1842531A1 Composition containing capsicum natural extracts
10/10/2007	EP1841811A2 Improvements relating to rapidly dissolving compositions
10/10/2007	EP1841805A1 Low-emission adhesive composition based on a solvent
10/10/2007	EP1841520A1 Metal containing composite materials
10/10/2007	EP1841432A1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
10/10/2007	EP1841427A2 Compositions and therapeutic methods utilizing a combination of a 5-ht1f inhibitor and an nsaid
10/10/2007	EP1841414A1 Rosiglitazone and metformin formulations
10/10/2007	EP1841413A2 Direct compression formulation and process
10/10/2007	EP1841412A2 Controlled long acting release pharmaceutical preparation for use in the oral cavity
10/10/2007	EP1841411A2 Sustained release pharmaceutical formulations comprising ranolazine
10/10/2007	EP1841410A1 Hydrophilic beads for use in topical formulations
10/10/2007	EP1841409A2 Dosage form for treating gastrointestinal disorders
10/10/2007	EP1841408A2 Deliverly of bio-available compounds with anhydrous topical preparations
10/10/2007	EP1841407A2 Medical devices containing crazed polymeric release regions for drug delivery
10/10/2007	EP1841403A1 Cosmetic patch for skin treatment
10/10/2007	EP1841389A2 Method for making a reservoir containing an active substance diffused through the reservoir and installation therefor
10/10/2007	EP1841380A2 Superabsorbent pad
10/10/2007	EP1841355A1 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm
10/10/2007	EP1758591B1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology
10/10/2007	EP1732487B1 Medical plaster for application on the skin
10/10/2007	EP1697050B1 Fiber rich fraction of trigonella foenum-graceumseeds and its use as a pharmaceutical excipient
10/10/2007	EP1670480A4 Use of steroids to treat ocular disorders
10/10/2007	EP1646328B1 Treatment of dependence withdrawal
10/10/2007	EP1617850A4 Delivery vehicle for silver ions
10/10/2007	EP1603544B1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo 2.2.1 heptan-2-amine
10/10/2007	EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007	EP1471894B1 Cyclodextrines for use as suspension stabilizers in pressure-liquefied propellants
10/10/2007	EP1427398B1 Device for the administration of an active agent to the human skin
10/10/2007	EP1414843B1 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
10/10/2007	EP1404295B1 Sustained release drug delivery devices with coated drug cores
10/10/2007	EP1399153B1 Pharmaceutical composition comprising orlistat and a fatty acid or salt thereof
10/10/2007	EP1372608B1 Medical aerosol formulations
10/10/2007	EP1364718B1 Device and method for producing stationary multi-component liquid capillary streams and micrometric and nanometric sized capsules
10/10/2007	EP1343478B1 Induced phase transition method for the production of microparticles containing hydrophilic active agents
10/10/2007	EP1265683B1 Methods for extraction and reaction using supercritical fluids
10/10/2007	EP1261317B1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders

1 ... 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 ... 2991